Search research articles
Contact Us
Filters
Showing results (271-280 of 326) with videos related to
Page
of 33
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2017
Parathyroid hormone controls paracellular Ca<sup>2+</sup> transport in the thick ascending limb by regulating the tight-junction protein Claudin14
Tadatoshi Sato, Marie Courbebaisse, Noriko Ide, et al.
The Journal of Clinical Investigation
|
March 1, 1994
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype
M R Pollak, Y H Chou, S J Marx, et al.
Journal of the American Society of Nephrology : JASN
|
September 22, 2012
Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria
Hakan R Toka, Khaldoun Al-Romaih, Jacob M Koshy, et al.
Kidney International
|
June 29, 2016
Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury
Balajikarthick Subramanian, Hua Sun, Paul Yan, et al.
Journal of the American Society of Nephrology : JASN
|
November 16, 2013
Plasma apolipoprotein L1 levels do not correlate with CKD
Leslie A Bruggeman, John F O'Toole, Michael D Ross, et al.
Nature
|
December 31, 2005
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor
Gregor B Adams, Karissa T Chabner, Ian R Alley, et al.
Kidney360
|
September 21, 2022
The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKD
Kenneth V Lieberman, Alexander R Chang, Geoffrey A Block, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2015
APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases
Opeyemi A Olabisi, Jia-Yue Zhang, Lynn VerPlank, et al.
Cardiorenal Medicine
|
June 15, 2017
Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization
Hanghang Wang, Patrick H Pun, Lydia Kwee, et al.
Journal of the American Society of Nephrology : JASN
|
March 2, 2022
DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants
Justin Chun, Cristian V Riella, Hyunjae Chung, et al.
Page
of 33
Search research articles
Search
Showing results (271-280 of 326) with videos related to
Sort By:
Page
of 33
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2017
Parathyroid hormone controls paracellular Ca<sup>2+</sup> transport in the thick ascending limb by regulating the tight-junction protein Claudin14
Tadatoshi Sato, Marie Courbebaisse, Noriko Ide, et al.
The Journal of Clinical Investigation
|
March 1, 1994
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype
M R Pollak, Y H Chou, S J Marx, et al.
Journal of the American Society of Nephrology : JASN
|
September 22, 2012
Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria
Hakan R Toka, Khaldoun Al-Romaih, Jacob M Koshy, et al.
Kidney International
|
June 29, 2016
Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury
Balajikarthick Subramanian, Hua Sun, Paul Yan, et al.
Journal of the American Society of Nephrology : JASN
|
November 16, 2013
Plasma apolipoprotein L1 levels do not correlate with CKD
Leslie A Bruggeman, John F O'Toole, Michael D Ross, et al.
Nature
|
December 31, 2005
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor
Gregor B Adams, Karissa T Chabner, Ian R Alley, et al.
Kidney360
|
September 21, 2022
The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKD
Kenneth V Lieberman, Alexander R Chang, Geoffrey A Block, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2015
APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases
Opeyemi A Olabisi, Jia-Yue Zhang, Lynn VerPlank, et al.
Cardiorenal Medicine
|
June 15, 2017
Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization
Hanghang Wang, Patrick H Pun, Lydia Kwee, et al.
Journal of the American Society of Nephrology : JASN
|
March 2, 2022
DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants
Justin Chun, Cristian V Riella, Hyunjae Chung, et al.
Page
of 33